Meeting News Archives - SOHO Insider

Skip to content

EC approves imetelstat for transfusion-dependent anemia in lower-risk MDS
Researchers document peripheral T-cell lymphomas across Latin America
How do lifestyle factors play a role in the response to CAR-T therapy?
Patient case highlights secondary tumor after CAR-T treatment for myeloma
Olutasidenib plus azacitidine show ‘durable’ responses in relapsed or refractory IDH1-mutated AML

Join SOHO

Home
About
Society Updates
- Society Updates
- Join SOHO
Resources
News
- Cellular Therapy
- Leukemia
  - ALL
  - AML
  - CLL
  - CML
- Lymphoma
  - ABCL
  - IBCL
  - MCL
  - TCL
- MDS
- MPN
- Multiple Myeloma
Meeting News
Roundtable Discussions
Subscribe

About Us

The Society of Hematologic Oncology (SOHO) was established as a non-profit corporation in 2012 with aims to promote worldwide research, education, prevention, clinical studies and optimal patient care in all aspects of hematologic malignancies and related disorders.

Join SOHO

Deeper MRD response associated with better survival in obe-cel-treated patients with B-cell ALL

by SOHO Insider Editors
February 25, 2025
0 Comments

Flipping of sheets of calendar with black and red numbers

2025 Tandem Meetings Meeting News

Earlier administration of CAR-T treatment may improve survival in LBCL

by SOHO Insider Editors
February 24, 2025
0 Comments

Lymphoma Meeting News The Twelfth Annual Meeting of the Society of Hematologic Oncology

Dr. Kriachok on Ukrainian patients navigating both war, blood cancer care

by sohonews
November 21, 2024
0 Comments

Meeting News The Twelfth Annual Meeting of the Society of Hematologic Oncology Video Interviews

Dr. Kantarjian on 40 years of progress in CML care

by sohonews
November 21, 2024
0 Comments

Meeting News The Twelfth Annual Meeting of the Society of Hematologic Oncology Video Interviews

Drs. Shah, Jain Discuss CAR-T Cell Therapy Advances at SOHO 2024

by sohonews
November 14, 2024
0 Comments

Meeting News The Twelfth Annual Meeting of the Society of Hematologic Oncology Video Interviews

Nitin Jain, MD, on Innovative Therapies in CLL

by sohonews
November 8, 2024
0 Comments

Meeting News

Momelotinib has greater anemia-related benefits in myelofibrosis

by sohonews
October 22, 2024
0 Comments

Meeting News

Meta-Analysis Investigates Daratumumab-Integrated Quadruple Therapy for Newly Diagnosed, Transplant-Eligible Patients With Multiple Myeloma

by sohonews
October 22, 2024
0 Comments

Meeting News

High ‘Clinical Burden’ Despite Therapy Advances in Heavily Pretreated Patients With Relapsed Or Refractory Myeloma

by sohonews
October 22, 2024
0 Comments

Meeting News

Poster Winners Awarded at 12th Annual SOHO Meeting

by sohonews
October 22, 2024
0 Comments

1
2

POPULAR NEWS

Acute Myeloid Leukemia , Leukemia , Myelodysplastic Syndromes

NCI’s myeloMATCH pushes the envelope in myeloid leukemia care

January 3, 2025

66th American Society of Hematology Annual Meeting & Exposition , Leukemia

Asciminib benefit-risk profile bests other TKIs in CML

December 10, 2024

Aggressive B-Cell Lymphomas , Lymphoma , News

Presence of circulating lymphoma cells a significant adverse risk factor in DLBCL

January 9, 2025

Top Categories

Cellular Therapy

7

Leukemia

24

Lymphoma

21

Multiple Myeloma

17

Myelodysplastic Syndromes

11

Myeloproliferative Neoplasms

7

The Society of Hematologic Oncology (SOHO) was established as a non-profit corporation in 2012 with aims to promote worldwide research, education, prevention, clinical studies and optimal patient care in all aspects of hematologic malignancies and related disorders.

About Us

Categories

Cellular Therapy

Leukemia

Lymphoma

Multiple Myeloma

Myelodysplastic Syndromes

Myeloproliferative Neoplasms

Contact Info

Deeper MRD response associated with better survival in obe-cel-treated patients with B-cell ALL

Earlier administration of CAR-T treatment may improve survival in LBCL

Dr. Kriachok on Ukrainian patients navigating both war, blood cancer care

Dr. Kantarjian on 40 years of progress in CML care

Drs. Shah, Jain Discuss CAR-T Cell Therapy Advances at SOHO 2024

Nitin Jain, MD, on Innovative Therapies in CLL

Momelotinib has greater anemia-related benefits in myelofibrosis

Meta-Analysis Investigates Daratumumab-Integrated Quadruple Therapy for Newly Diagnosed, Transplant-Eligible Patients With Multiple Myeloma

High ‘Clinical Burden’ Despite Therapy Advances in Heavily Pretreated Patients With Relapsed Or Refractory Myeloma

Poster Winners Awarded at 12th Annual SOHO Meeting

Categories

Cellular Therapy

Leukemia

Lymphoma

Multiple Myeloma

Myelodysplastic Syndromes

Myeloproliferative Neoplasms

Recent Posts

EC approves imetelstat for transfusion-dependent anemia in lower-risk MDS

Researchers document peripheral T-cell lymphomas across Latin America

How do lifestyle factors play a role in the response to CAR-T therapy?

About Us

Categories

Cellular Therapy

Leukemia

Lymphoma

Multiple Myeloma

Myelodysplastic Syndromes

Myeloproliferative Neoplasms

Contact Info

Follow Us

Cellular Therapy

Leukemia

Lymphoma

Multiple Myeloma

Myelodysplastic Syndromes

Myeloproliferative Neoplasms